3Pound CR,Partin AW,Eisenberger MA. Natural history of progression after PSA elevation following radical prostatectomy. JAM A, 1999,281 : 1591 - 1597.
4Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology ,2003,61:32 - 38.
5Isaacs JT, Coffey DS. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R - 3327 - H adenocarcinoma. Cancer Res, 1981,41 ( 12 Pt 1 ) : 5070 - 5075.
6Feldman B J, Feldman D. The development of androgen - independent prostate cancer. Nat Rev Cancer,2001 ( 1 ), 1:34 -45.
7Craft N, Shostak Y, Carey M, et al. A mechanism for hormone - independent prostate cancer through modulation of androgen receptor signaling by the HER -2/neu tyrosine kinase. Nat Med, 1999,5:280 - 285.
8Bruchovsky N, Rennie PS, Coldman A J, et al. Effects of androgen with - drawal on the stem cell composition of the Shionogi carcinoma. Cancer Res, 1990,50 : 2275 - 2282.
9Akakura K, Bruehovsky N, Goldenberg SL, et al. Effects of intermittent androgen suppression on androgen -dependent tumors. Apoptosis and serum prostate - specific antigen. Cancer, 1993,71 ( 9 ) : 2782 - 2790.
10Akakura K, Bruchovsky N, Rennie PS, et al. Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM - 2 ( clusterin ) gene in the Shionogi carcinoma. J Steroid Biochem Mol Biol, 1996,58 : 139 - 146.
2Van Poppel H,Nillsson S.Testosterone surge:rationale for gonadotropinreleasing hormone blockers[J].Urology,2008,71:1001.
3Eastbam JA.Bone bealth in men receiving androgen deprivation therapy for prostate cancer[J].J Urol,2007,177(1):17-24.
4Fernando E.C. Calais da Silva,Aldo V. Bono,Peter Whelan,Maurizio Brausi,Anton Marques Queimadelos,Jose A. Portillo Martin,Ziya Kirkali,Fernando M.V. Calais da Silva,Chris Robertson.Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group[J]. European Urology . 2009 (6)
5James A. Eastham.Bone Health in Men Receiving Androgen Deprivation Therapy for Prostate Cancer[J]. The Journal of Urology . 2007 (1)
